SMTL ID : 3p0y.1

anti-EGFR/HER3 Fab DL11 in complex with domain III of EGFR extracellular region

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

hetero-1-1-1-mer

Ligands

2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 11 residues within 4Å: Chain A: D.14, S.15, L.16, S.17, N.19, T.21, N.22, V.41, D.46, T.49, T.51 No protein-ligand interaction detected (PLIP) NAG-NAG.3: 8 residues within 4Å: Chain A: E.79, N.80, N.111, T.113, N.135 Chain B: S.211, N.212, T.213 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:N.212

1 x NAG- NAG- FUL: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-FUL.2: 11 residues within 4Å: Chain A: Q.57, N.80, R.81 Chain B: K.125, P.127, S.128, V.129, F.130, V.215, K.217 Chain C: E.123 6 PLIP interactions: 4 interactions with chain B, 1 interactions with chain C, 1 interactions with chain A Hydrogen bonds: B:K.125, B:V.129, B:K.217, B:K.217 Water bridges: B:S.128, C:S.127, A:N.80 Hydrophobic interactions: B:F.130

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.4: 4 residues within 4Å: Chain B: N.163, A.166, L.167, Q.200 3 PLIP interactions: 3 interactions with chain B Hydrogen bonds: B:N.163, B:A.166 Water bridges: B:T.168

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Schaefer, G. et al., A two-in-one antibody against HER3 and EGFR has superior inhibitory activity compared with monospecific antibodies. Cancer Cell (2011)

Release Date

2011-10-26

Peptides

Epidermal growth factor receptor: A
Fab DL11 heavy chain: B
Fab DL11 light chain: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
H

C
L

Epidermal growth factor receptor

Fab DL11 heavy chain

Fab DL11 light chain

Related Entries With Identical Sequence